When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases

How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Hong Kong Exchange: Nurturing China’s Biotech Valley

Biopharma R&D in the Post-COVID World

eBook: Biopharma in the COVID-19 World

Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Is Cardiovascular R&D Ready for a Comeback?

Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

eBook: Digital Health and the Global Pandemic

SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future

COVID-19 Impact on Rare Disease Patients and Manufacturers

Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks

Launch Costs—Spend Wisely: Analysis by Order of Entry

Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition)

Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition)

How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

Biopharma Sales Resilience through Economic Recession

Heart Attacks are Still Killing Us

Health Advances Blog

Author: healthadvances

When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases

How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Hong Kong Exchange: Nurturing China’s Biotech Valley

Biopharma R&D in the Post-COVID World

eBook: Biopharma in the COVID-19 World

Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Is Cardiovascular R&D Ready for a Comeback?

Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

eBook: Digital Health and the Global Pandemic

SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future

COVID-19 Impact on Rare Disease Patients and Manufacturers

Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks

Launch Costs—Spend Wisely: Analysis by Order of Entry

Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition)

Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition)

How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

Biopharma Sales Resilience through Economic Recession

Heart Attacks are Still Killing Us